NCT04482933 2026-02-10
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Pediatric Brain Tumor Consortium
Phase 2 Withdrawn
Clinical Trials
7 trialsNCT00114140 2024-07-08
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
Radiation Therapy Oncology Group
Phase 2 Completed
NCT00033280 2020-10-22
Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
Radiation Therapy Oncology Group
Phase 2 Completed
NCT00003372 2020-04-08
Topotecan in Treating Patients With Recurrent Brain Tumors
Canadian Cancer Trials Group
Phase 2 Completed
NCT01164189 2019-02-28
TAVAREC
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00003731 2012-09-24
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00039364 2012-07-24
Imatinib Mesylate in Treating Patients With Gliomas
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed